Warfarin versus aspirin for stroke prevention in an elderly community population with atrial fibrillation (the Birmingham Atrial Fibrillation Treatment of the Aged Study, BAFTA): A randomised controlled trial

被引:0
|
作者
Estes, N. A. Mark, III [1 ]
机构
[1] Tufts Univ, Sch Med, New England Cardiac Arrhythmia Ctr, Div Cardiol,Dept Med, Boston, MA 02111 USA
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:166 / 166
页数:1
相关论文
共 50 条
  • [1] Warfarin versus aspirin for stroke prevention in an elderly community population with atrial fibrillation (the Birmingham Atrial Fibrillation Treatment of the Aged Study, BAFTA): a randomised controlled trial
    Mant, Jonathan
    Hobbs, F. D. Richard
    Fletcher, Kate
    Roalfe, Andrea
    Fitzmaurice, David
    Lip, Gregory Y. H.
    Murray, Ellen
    LANCET, 2007, 370 (9586): : 493 - 503
  • [2] BAFTA study - Warfarin versus aspirin for stroke prevention in an elderly community population with atrial fibrillation
    Buksinska-Lisik, Malgorzata
    KARDIOLOGIA POLSKA, 2007, 65 (11) : 1399 - 1402
  • [3] Protocol for Birmingham Atrial Fibrillation Treatment of the Aged study (BAFTA): a randomised controlled trial of warfarin versus aspirin for stroke prevention in the management of atrial fibrillation in an elderly primary care population [ISRCTN89345269]
    Jonathan WF Mant
    Suzanne H Richards
    FD Richard Hobbs
    David Fitzmaurice
    Gregory YH Lip
    Ellen Murray
    Miriam Banting
    Kate Fletcher
    Joy Rahman
    Teresa Allan
    James Raftery
    Stirling Bryan
    BMC Cardiovascular Disorders, 3
  • [4] Protocol for Birmingham Atrial Fibrillation Treatment of the Aged study (BAFTA): a randomised controlled trial of warfarin versus aspirin for stroke prevention in the management of atrial fibrillation in an elderly primary care population [ISRCTN89345269]
    Mant, Jonathan W. F.
    Richards, Suzanne H.
    Hobbs, F. D. Richard
    Fitzmaurice, David
    Lip, Gregory Y. H.
    Murray, Ellen
    Banting, Miriam
    Fletcher, Kate
    Rahman, Joy
    Allan, Teresa
    Raftery, James
    Bryan, Stirling
    BMC CARDIOVASCULAR DISORDERS, 2003, 3 (1)
  • [5] Warfarin versus aspirin for prevention of cognitive decline in an elderly community population with atrial fibrillation (the BAFTA Study): a randomised controlled trial
    Mavaddat, N.
    Mant, J.
    Roalfe, A.
    Fletcher, K.
    Lip, G.
    Hobbs, F. D. R.
    Fitzmaurice, D.
    INTERNATIONAL JOURNAL OF STROKE, 2013, 8 : 5 - 5
  • [7] A randomised controlled trial of warfarin versus aspirin for stroke prevention in octogenarians with atrial fibrillation (WASPO)
    Rash, Amar
    Downes, Tom
    Portner, Robin
    Yeo, Wilf W.
    Morgan, Nicolette
    Channer, Kevin S.
    AGE AND AGEING, 2007, 36 (02) : 151 - 156
  • [8] Response to Letter Regarding Article, "Warfarin Versus Aspirin for Prevention of Cognitive Decline in Atrial Fibrillation: Randomized Controlled Trial (Birmingham Atrial Fibrillation Treatment of the Aged Study)"
    Mavaddat, Nahal
    Roalfe, Andrea
    Fletcher, Kate
    Lip, Gregory Y. H.
    Hobbs, F. D. Richard
    Fitzmaurice, David
    Mant, Jonathan
    STROKE, 2014, 45 (09) : E192 - E192
  • [9] Letter by Zito et al Regarding Article, "Warfarin Versus Aspirin for Prevention of Cognitive Decline in Atrial Fibrillation: Randomized Controlled Trial (Birmingham Atrial Fibrillation Treatment of the Aged Study)"
    Zito, Stefano
    Lattanzio, Francesco
    Di Nisio, Marcello
    STROKE, 2014, 45 (09) : E191 - E191
  • [10] A cross-sectional study of hypertension in an elderly population (75 years and over) with atrial fibrillation: Secondary analysis of data from the Birmingham Atrial Fibrillation in the Aged (BAFTA) randomised controlled trial
    Hurley, Victoria
    Ireson, Rosa
    Fletcher, Kate
    Lip, Gregory Y. H.
    Hobbs, F. D. Richard
    Mant, Jonathan
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2007, 117 (02) : 152 - 156